| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |